More Telix Pharmaceuticals Limited news
Telix Pharmaceuticals LimitedASX: TLX

Prostate imaging regulatory update - FDA review of DMF

Jul 24, 2018 at 11:18 PM EDT · Issued by Telix Pharmaceuticals Limited

Filed with ASX · Jul 24, 2018 at 11:18 PM EDT · 2 pages · English

On 6ix: 6ix.com/news/prostate-imaging-regulatory-update-fda-review-of-dmf

Watch Telix Pharmaceuticals' latest call↗Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call · Replay · Aug 20Read the transcript of Telix Pharmaceuticals (ASX:TLX) Q2 2026 Earnings Call↗

Telix Pharmaceuticals Limited on 6ix

Story so far

  • Drug Master File for Prostate Imaging Product Filed with FDAMar 26, 2018

Earlier from Telix Pharmaceuticals

  • Telix and Isologic conclude manufacturing agreementJun 25, 2018
  • SEIF Grant Awarded for Advanced Biologics ManufacturingJun 17, 2018
  • Telix and Osaka U receive funding for Alpha Nuclide ResearchMay 29, 2018
  • Appendix 4C - March 2018 quarterApr 26, 2018
  • Translational Research Partnership with INSERM and ARRONAXApr 15, 2018

Later from Telix Pharmaceuticals

  • TLX and JFE progress Japanese manufacturing partnershipJul 25, 2018
  • Appendix 4C - June 2018 QuarterJul 26, 2018
  • Telix receives $55m Overseas FindingAug 2, 2018
  • Telix JV Entity Extends Contract with Endocyte to Include EUAug 9, 2018
  • Collaboration on Renal Cancer Imaging for Japanese marketAug 15, 2018
All Telix Pharmaceuticals news releases↗

Follow Telix Pharmaceuticals into a list and get an email when it puts out news.

Follow Telix Pharmaceuticals
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer